Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
New Publication: Opportunity Costs and Local Health Service Spending Decisions – A Qualitative Study from Wales
26 April 2016
Work by Sarah Karlsberg Schaffer (OHE), Jon Sussex (RAND Europe), Dyfrig Hughes (Bangor University) and Nancy Devlin (OHE) has recently been published in BMC Health Services…
New OHE Consulting Report on Shaping Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
18 April 2016
OHE publishes new Consulting Report on shaping the research agenda to estimate relevant cost-effectiveness thresholds for Health Technology Assessment decision making.
Spotlight on OHE: Beyond QALYs, Managed Entry Agreements, Business Models for Antibiotics, and the UK Market for Medicines.
12 April 2016
The blog provides links to slide sets for presentations relating to going ‘beyond QALYs’ when valuing health care interventions, managed entry agreements within the UK pharmaceutical…
OHE Lunchtime Seminar on 19 April 2016: Evidence that challenges decision makers: experiences and examples
29 March 2016
Dr Amanda Adler, Chair of NICE Appraisal Committee B and Consultant Physician, will present an OHE Seminar on 19 April 2016.
New OHE Publications: An EQ-5D-5L Value Set for England
22 March 2016
Two newly published OHE Research Papers report the methods and findings of the ‘EQ-5D-5L value set for England’ study.
Recently published: Are Wider Societal Effects Considered in Healthcare Decision-making?
29 February 2016
Health interventions can produce economic gains for patients and national economies. In practice, however, the health-wealth link is rarely considered.
Just Published: OHE Report on Trends in Scottish Medicines Committee Advice Decisions
25 February 2016
An analysis in the trends in Scottish Medicines Committee (SMC) advice decisions for medicines for the period October 2009 to September 2015 has just been published…
New Publication: Headroom Approach to Device Development
23 February 2016
OHE’s Amanda Cole co-authors a new publication on the headroom approach, which can help assess the commercial value and viability of medical device development.
New ISPOR Task Force Report on Multiple Criteria Decision Analysis
9 February 2016
Professor Nancy Devlin co-chaired the ISPOR task force on uses of MCDA in health care decision making. The first report from the task force has just…